Analysts expect Foghorn Therapeutics Inc. to report revenue of 6.64 M for Q3 26, against a range of 6.40 M to 6.87 M. The most recent reported quarter, Q2 26, came in at 16.09 M, a 145.2% beat against the 6.56 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 7.80 M | 2.86 M | 5.95 M | 7.56 M | 8.15 M | 9.25 M | 3.27 M | 16.09 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 6.76 M | 7.25 M | 6.81 M | 5.97 M | 6.88 M | 10.05 M | 8.59 M | 7.20 M | 6.87 M | 8.29 M | 6.38 M | 9.64 M | 6.43 M | 8.65 M | 10.15 M | 18.25 M | ||||||||||
| Low Estimate | 6.28 M | 6.67 M | 5.92 M | 5.51 M | 6.12 M | 9.12 M | 8.01 M | 5.93 M | 6.40 M | 7.64 M | 5.24 M | 7.95 M | 5.92 M | 7.32 M | 8.40 M | 15.45 M | ||||||||||
| Consensus Estimate | 6.52 M | 6.96 M | 6.37 M | 5.74 M | 6.50 M | 9.58 M | 8.30 M | 6.56 M | 6.64 M | 7.96 M | 5.81 M | 8.80 M | 6.18 M | 7.98 M | 9.28 M | 16.85 M |
Analysts expect Foghorn Therapeutics Inc. to report earnings per share of -0.23 for Q3 26, against a range of -0.24 to -0.22. The most recent reported quarter, Q2 26, came in at -0.10, a 60.0% beat against the -0.25 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.31 | -0.23 | -0.30 | -0.28 | -0.25 | -0.35 | -0.29 | -0.10 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.38 | -0.28 | -0.27 | -0.30 | -0.31 | -0.23 | -0.30 | -0.23 | -0.22 | -0.20 | -0.22 | -0.20 | -0.26 | -0.21 | -0.17 | -0.10 | ||||||||||
| Low Estimate | -0.42 | -0.32 | -0.31 | -0.36 | -0.37 | -0.25 | -0.32 | -0.27 | -0.24 | -0.22 | -0.26 | -0.24 | -0.30 | -0.23 | -0.19 | -0.12 | ||||||||||
| Consensus Estimate | -0.40 | -0.30 | -0.29 | -0.33 | -0.34 | -0.24 | -0.31 | -0.25 | -0.23 | -0.21 | -0.24 | -0.22 | -0.28 | -0.22 | -0.18 | -0.11 |
Pull Wall Street consensus for Foghorn Therapeutics Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=FHTX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "FHTX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=FHTX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();